Stereotaxis technology to be showcased at the Heart Rhythm Society annual meeting

114

Stereotaxis has announced that it will highlight clinical results from the first 1,250 cases and the latest innovations for the Epoch platform for the electrophysiology laboratory, at the 33rd Annual Heart Rhythm Society (HRS) Scientific Sessions (9–12May, 2012, Boston, USA).

The company announced that a total of 11 invited podium presentations will feature the use of Stereotaxis magnetic navigation technology in a wide variety of arrhythmias. In addition, 13 submitted abstracts that feature or discuss Stereotaxis technology are included in this year’s HRS programme. Highlights of these submitted abstracts include comparative data on VT ablation, multicentre VT data, lesion formation, paediatric outcome data, and the first large series of Vdrive system’s clinical outcomes data.

Stereotaxis will unveil a broad number of product innovations for the Niobe ES, Vdrive and Odyssey platforms scheduled to be shipped in 2012. The innovations include advancements in linear line formation and testing, Vdrive offering and Odyssey remote collaboration.

(Visited 15 times, 1 visits today)